Join a Phase III Clinical Research Study Evaluating an Investigational Oral Treatment Designed to Help Reduce the Risk of Future Heart Attacks, Stroke, and Other Serious Cardiovascular Events.

If you’ve had a heart attack, stroke, peripheral artery disease, or have other cardiovascular risk factors, you may qualify for a clinical research study evaluating an investigational once-daily oral medication.

You may receive:

• Study-related care at no cost
• Access to an investigational oral treatment or placebo
• Regular health monitoring by cardiovascular research specialists
• Continued standard cholesterol-lowering treatment throughout the study

Why Is This Study Being Conducted?

Cardiovascular disease remains one of the leading causes of death worldwide.

Even when taking cholesterol-lowering medications, many people continue to have elevated LDL (“bad”) cholesterol levels and remain at risk for future cardiovascular events.

Researchers are evaluating an investigational oral medication designed to help lower LDL cholesterol through a different approach than currently available treatments.

The goal is to determine whether this investigational therapy may help reduce the risk of:

• Heart attack
• Stroke
• Cardiovascular death
• Urgent artery procedures
• Serious circulation-related complications

Who May Qualify?

You may be eligible if you have a history of Cardiovascular Disease such as:

• Previous heart attack
• Previous ischemic stroke
• Peripheral artery disease (PAD)
• Prior artery procedures or vascular interventions

OR

Are at High Risk for a First Cardiovascular Event

You may qualify if you have certain risk factors such as:

• High LDL cholesterol
• Diabetes
• Kidney disease
• Evidence of atherosclerosis (plaque buildup in the arteries)
• Other cardiovascular risk factors

Additional study criteria apply.

What Can Participants Expect?

• Screening Visit: Study doctors will review your medical history and determine whether you qualify.
• Study Participation: If eligible, you may be randomly assigned to receive the investigational study medication or placebo.
• Ongoing Monitoring: Participants receive regular study visits that may include:
  • Physical examinations
  • Blood tests
  • Heart health assessments
  • Cholesterol monitoring
  • Safety evaluations
• Continued Standard Care: Participants remain on their regular cholesterol-lowering treatment throughout the study unless changes are medically necessary.

Take the First Step Today
See If You May Qualify for This Cardiovascular Research Study

Help advance research into potential new treatments designed to reduce the risk of future cardiovascular events.